We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Chinese consumers, once the engine of growth for multinational companies, are cutting back on all kinds of things. Designer ...

This week, the European Commission granted approval to Merck’s MRK novel HIF-2α inhibitor, Welireg, for two indications. The ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

Kineta has found a new home for deals with Genentech and Merck & Co. Tidying up the portfolio ahead of its merger with TuHURA ...

We recently compiled a list of the 13 Cheap High Dividend Stocks To Invest In Now. In this article, we are going to take a ...

Merck & Co’s CEO Kenneth Frazier ... September that showed the reputation of the pharma industry was at rock bottom, below all others on the list. Among those questioned 58% had a “totally ...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But ...

Welcome to Fierce ... The drug cost watchdog changed its mind after BMS "offered an improved commercial arrangement" to the NHS based on its 297,000 pound sterling (about $375,000) list price ...

We recently compiled a list of the 10 Best Dow Jones Dividend Stocks According to Wall Street Analysts. In this article, we ...